Allied Biotech Corporation (TPEX:1780)
Taiwan
· Delayed Price · Currency is TWD 26.00
-0.40 (-1.52%)
Mar 9, 2026, 1:17 PM CST
Allied Biotech Revenue
Allied Biotech had revenue of 210.17M TWD in the quarter ending September 30, 2025, with 9.00% growth. This brings the company's revenue in the last twelve months to 821.81M, up 3.86% year-over-year. In the year 2024, Allied Biotech had annual revenue of 806.92M with 12.00% growth.
Revenue (ttm)
821.81M
Revenue Growth
+3.86%
P/S Ratio
3.06
Revenue / Employee
20.55M
Employees
40
Market Cap
2.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 806.92M | 86.49M | 12.00% |
| Dec 31, 2023 | 720.43M | 3.69M | 0.51% |
| Dec 31, 2022 | 716.75M | 39.99M | 5.91% |
| Dec 31, 2021 | 676.76M | 58.69M | 9.50% |
| Dec 31, 2020 | 618.07M | -21.33M | -3.34% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Johnson Chemical Pharmaceutical Works | 567.06M |
| PhytoHealth | 134.58M |
| Golden Biotechnology | 44.58M |
| Maywufa Company | 1.58B |
| TSH Biopharm Corporation | 1.34B |
| Merdury Biopharmaceutical | 246.00K |
| Easywell Biomedicals | 588.89M |
| LIWANLI Innovation | 125.54M |